Logo image of AIM

AIM IMMUNOTECH INC (AIM) Stock Analyst Ratings

USA - NYSE Arca - NYSEARCA:AIM - US00901B3033 - Common Stock

1.52 USD
+0.01 (+0.66%)
Last: 11/28/2025, 5:04:00 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to AIM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 24.48. This target is 1510.53% above the current price.
AIM was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AIM.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed AIM. So this is just the average opinion of a couple of analysts.
AIM Historical Analyst RatingsAIM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -84 -76 -68 -60 -52 -44 -36 -28 -20 -12 -4 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.5224.2424.4824.4825.20 - 1,494.74% 1,510.53% 1,510.53% 1,557.89%
AIM Current Analyst RatingAIM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-10-03 Ascendiant Capital Maintains Buy -> Buy
2024-12-10 Ascendiant Capital Maintains Buy -> Buy
2024-10-22 Maxim Group Maintains Buy -> Buy
2024-09-03 Ascendiant Capital Maintains Buy -> Buy

AIM IMMUNOTECH INC / AIM FAQ

What is the average price target for AIM IMMUNOTECH INC (AIM) stock?

5 analysts have analysed AIM and the average price target is 24.48 USD. This implies a price increase of 1510.53% is expected in the next year compared to the current price of 1.52.


What is the consensus rating for AIM IMMUNOTECH INC (AIM) stock?

The consensus rating for AIM IMMUNOTECH INC (AIM) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed AIM IMMUNOTECH INC (AIM)?

The number of analysts covering AIM IMMUNOTECH INC (AIM) is 5.